Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.50 |
| ▸ | ATAD2 | Q6PL18 | 1/20 | 0.50 |
| ▸ | DPYD | Q12882 | 4/20 | 0.45 |
| ▸ | LMNA | P02545 | 3/20 | 0.45 |
| ▸ | MAPT | P10636 | 3/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | THPO | P40225 | 1/20 | 0.45 |
| ▸ | MTOR | P42345 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | HBB | P68871 | 1/20 | 0.45 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | KDM3B | Q7LBC6 | 1/20 | 0.42 |
| ▸ | PBRM1 | Q86U86 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9220471 | 0.81 | GAA (0.48) | GAAATAD2DPYDLMNAMAPT | |
| SCHEMBL127493 | 0.80 | KDM3B (0.64) | GAAATAD2DPYDLMNAMAPT | |
| SCHEMBL9959455 | 0.79 | KDM3B (0.69) | GAAMAPTALDH1A1HTTKDM3B | |
| SCHEMBL29029122 | 0.79 | KMT2A (0.44) | GAAATAD2DPYDLMNAMAPT | |
| SCHEMBL1210894 | 0.78 | GAA (0.50) | GAAATAD2DPYDLMNAMAPT | |
| SCHEMBL6524027 | 0.78 | GAA (0.50) | GAAATAD2DPYDLMNAMAPT | |
| Hydrochloric Acid SCHEMBL11439523 | 0.78 | KDM3B (0.62) | GAAATAD2DPYDLMNAMAPT | |
| Water SCHEMBL4487821 | 0.78 | KDM3B (0.62) | GAAATAD2DPYDLMNAMAPT | |
| SCHEMBL12031568 | 0.78 | GAA (0.45) | GAAATAD2DPYDLMNAMAPT | |
| Dimethylamine SCHEMBL1524840 | 0.78 | KDM3B (0.56) | GAAATAD2DPYDLMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 231 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4560315-A2 | HYBRIDIZING ALL-LNA OLIGONUCLEOTIDES | F. Hoffmann-La Roche AG (CH) | 2025-05-28 | — | — | EP | claimed |
| CN-119924314-A | Neutral peroxyacetic acid disinfectant for endoscope disinfection | 山东新华医疗器械股份有限公司 | 2025-05-06 | — | — | CN | claimed |
| EP-3980554-B1 | HYBRIDIZING ALL-LNA OLIGONUCLEOTIDES | HOFFMANN LA ROCHE (CH) | 2025-03-26 | — | — | EP | claimed |
| US-20220195497-A1 | HYBRIDIZING all-LNA OLIGONUCLEOTIDES | ROCHE DIAGNOSTICS OPERATIONS, INC. | 2022-06-23 | — | — | US | claimed |
| EP-3980554-A1 | HYBRIDIZING ALL-LNA OLIGONUCLEOTIDES | F. Hoffmann-La Roche AG (CH) | 2022-04-13 | — | — | EP | claimed |
| CN-114269080-A | System packaging module half-hole burr processing improvement method, packaging plate and application | 珠海中京电子电路有限公司 | 2022-04-01 | — | — | CN | claimed |
| CN-113939599-A | Hybrid all-LNA oligonucleotides | 豪夫迈·罗氏有限公司 | 2022-01-14 | — | — | CN | claimed |
| WO-2020245377-A1 | HYBRIDIZING ALL-LNA OLIGONUCLEOTIDES | F. HOFFMANN-LA ROCHE AG (CH) | 2020-12-10 | — | — | WO | claimed |
| US-4243749-A | Immunoassay employing an enzyme label | MILES YEDA LTD. (IL) | 1981-01-06 | — | — | US | claimed |
| US-12593845-B2 | 2,6-dioxo-3,6-dihydropyrimidine compound, agricultural and horticultural bactericide, nematicide, and medical and veterinary antifungal agent | NIPPON SODA CO., LTD. (JP) | 2026-04-07 | — | — | US | disclosed |
| EP-4560315-A2 | HYBRIDIZING ALL-LNA OLIGONUCLEOTIDES | F. Hoffmann-La Roche AG (CH) | 2025-05-28 | — | — | EP | disclosed |
| CN-119924314-A | Neutral peroxyacetic acid disinfectant for endoscope disinfection | 山东新华医疗器械股份有限公司 | 2025-05-06 | — | — | CN | disclosed |
| EP-3980554-B1 | HYBRIDIZING ALL-LNA OLIGONUCLEOTIDES | HOFFMANN LA ROCHE (CH) | 2025-03-26 | — | — | EP | disclosed |
| US-20250017931-A1 | METHODS OF PERSONALIZING CANCER TREATMENT | PROCESSA PHARMACEUTICALS, INC., (US) | 2025-01-16 | — | — | US | disclosed |
| US-4806644-A | HERBICIDES, FUNGICIDES, PLANT GROWTH REGULATORS AND INTERMEDIATES | BAYER AKTIENGESELLSCHAFT (DE) | 1989-02-21 | — | — | US | disclosed |
| EP-0272065-A2 | Antiviral compounds | THE WELLCOME FOUNDATION LIMITED (GB) | 1988-06-22 | — | — | EP | disclosed |
| US-4713456-A | HERBICIDE INTERMEDIATES | BAYER AKTIENGESELLSCHAFT (DE) | 1987-12-15 | — | — | US | disclosed |
| EP-0208550-A2 | Antiviral compounds | THE WELLCOME FOUNDATION LIMITED (GB) | 1987-01-14 | — | — | EP | disclosed |
| EP-0173190-A2 | Process for the preparation of 5-acyl pyrimidines | BAYER AG (DE) | 1986-03-05 | — | — | EP | disclosed |
| US-4243749-A | Immunoassay employing an enzyme label | MILES YEDA LTD. (IL) | 1981-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12593845-B2 | 2,6-dioxo-3,6-dihydropyrimidine compound, agricultural and horticultural bactericide, nematicide, and medical and veterinary antifungal agent | CASP6, GMDS, HPD | GAA 2650/4885ATAD2 910/4885DPYD 132/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.